CN Patent

CN116075503A — 普拉替尼的固体形式

Assigned to Cable Chart Pharmaceutical Co · Expires 2023-05-05 · 3y expired

What this patent protects

化合物顺式)‑N‑((S)‑1‑(6‑(4‑氟‑1H‑吡唑‑1‑基)吡啶‑3‑基)乙基)‑1‑甲氧基‑4‑(4甲基‑6‑(5‑甲基‑1H‑吡唑‑3‑基氨基)嘧啶‑2‑基)环己烷甲酰胺可制备成呈多种结晶固体形式的游离碱，以及呈各自具有一种或多种固体形式的多种盐形式。

USPTO Abstract

化合物顺式)‑N‑((S)‑1‑(6‑(4‑氟‑1H‑吡唑‑1‑基)吡啶‑3‑基)乙基)‑1‑甲氧基‑4‑(4甲基‑6‑(5‑甲基‑1H‑吡唑‑3‑基氨基)嘧啶‑2‑基)环己烷甲酰胺可制备成呈多种结晶固体形式的游离碱，以及呈各自具有一种或多种固体形式的多种盐形式。

Drugs covered by this patent

Patent Metadata

Patent number
CN116075503A
Jurisdiction
CN
Classification
—
Expires
2023-05-05
Drug substance claim
No
Drug product claim
No
Assignee
Cable Chart Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.